Use of central cannabinoid receptor antagonist for preparing medicines
US6642258B1 · kind B1 · utility
29Cited by
1References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 21, 2002 |
| Grant date | Nov 4, 2003 |
| Priority date | — |
| Expiry date | Mar 21, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of a central cannabinoid receptor antagonist for the preparation of medicinal products that are useful in treating and preventing neuroinflammatory pathologies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.